- Presentations
- 3
- Markets
- 1
Reyataz is a brand of Atazanavir marketed by ER Squibb & Sons, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Atazanavir
- Brand owner
- ER Squibb & Sons
- Registered in
- United States
- Strengths and forms
- 200 mg capsule, 300 mg capsule, 50 mg oral powder
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Reyataz 200 mg capsuleOral | ER Squibb & Sons | US FDA | Available on request |
| Reyataz 300 mg capsuleOral | ER Squibb & Sons | US FDA | Available on request |
| Reyataz 50 mg oral powderOral | ER Squibb & Sons | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Reyataz
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.